FDA advisers vote to include an Omicron-specific component for a coronavirus booster

The U.S. Food and Drug Administration's independent Vaccines and Related Biological Products Advisory Committee voted Tuesday to support recommending inclusion of an Omicron-specific component for a COVID-19 booster vaccine.

Related Keywords

United States ,Melbourne ,Victoria ,Australia ,Archana Chatterjee ,Wayne Marasco ,Peter Marks ,Arnold Monto ,Kanta Subbarao ,Bruce Gellin ,Chicago Medical School ,Us Centers For Disease ,Warnermedia Company ,World Health Organization Collaborating Center ,World Health Organization ,Drug Administration ,Pfizer ,University Of Melbourne ,Division Of Viral Products ,Dana Farber Cancer Institute Harvard Medical School ,Rockefeller Foundation ,Products Advisory Committee ,Cable News Network Inc ,Related Biological Products Advisory Committee ,Dana Farber Cancer Institute Harvard Medical ,Disease Control ,Biologics Evaluation ,Viral Products ,Chicago Medical ,News Network ,Coronavirus ,News ,Ational ,